Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
01 1Medichem Manufacturing (Malta) Ltd.
02 1Medichem S.A.
03 1Granules India Limited
04 1Cipla Ltd.
05 1Formosa Laboratories, Inc.
06 1Hetero Labs Limited
07 1MSN Laboratories Private Limited
08 1Sionc Pharmaceutical Private Limited
09 1ZHEJIANG LEPU PHARMACETICAL CO., LTD.
01 1PAZOPANIB HYDROCHLORIDE
02 8Pazopanib Hydrochloride
01 1China
02 5India
03 2Spain
04 1Taiwan
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
NDC Package Code : 16436-0125
Start Marketing Date : 2020-11-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
NDC Package Code : 62207-977
Start Marketing Date : 2021-08-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.
NDC Package Code : 53296-0125
Start Marketing Date : 2020-11-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7727
Start Marketing Date : 2019-02-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66499-0055
Start Marketing Date : 2012-04-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0058
Start Marketing Date : 2009-10-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0014
Start Marketing Date : 2009-10-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76055-0050
Start Marketing Date : 2021-12-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68578-0015
Start Marketing Date : 2021-09-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
A Pazopanib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pazopanib, including repackagers and relabelers. The FDA regulates Pazopanib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pazopanib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pazopanib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pazopanib supplier is an individual or a company that provides Pazopanib active pharmaceutical ingredient (API) or Pazopanib finished formulations upon request. The Pazopanib suppliers may include Pazopanib API manufacturers, exporters, distributors and traders.
click here to find a list of Pazopanib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pazopanib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pazopanib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pazopanib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pazopanib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pazopanib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pazopanib suppliers with NDC on PharmaCompass.
We have 8 companies offering Pazopanib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
